Cynvenio Biosystems, Inc., a leader in liquid biopsy technology for cancer research and personalized medicine, today announced the launch of a new breast cancer monitoring study in partnership with Saint Luke’s Cancer Institute in Kansas City, Missouri.
Congenital heart disease kept Andrew on the sidelines for most of his life. See how a heart transplant gave him a chance to live life like never before.
The parade was to raise awareness for the benefits of breastfeeding and to show the support that the hospital offers for those who are breastfeeding their babies.
Saint Luke’s was one of the first hospitals to perform TAVR after it was approved roughly six years ago. See how this procedure helped a former professional baseball player.
For many women who were born with a heart condition, in the past, they were told not to have children. However, that is now changing because the care for those women has also changed.
Saint Luke’s Health System has signed an agreement with Washington University’s Alvin J. Siteman Cancer Center that will give its patients access to National Cancer Institute trials for new treatments.
Saint Luke’s Marion Bloch Neuroscience Institute is a national leader in stroke reversal. We treat more than 1,100 stroke patients each year from the Kansas City region and well beyond.
